Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weichao Bio is a biotechnology company specializing in the development of high-throughput microfluidic systems for single-cell analysis and molecular diagnostics. Based in the Suzhou Industrial Park, the company leverages droplet microfluidics to provide solutions for single-cell sequencing, digital PCR, and high-throughput screening. Their technology is designed to improve the precision and efficiency of biological research and clinical testing, particularly in oncology and immunology. Weichao Bio's product portfolio includes automated instruments and specialized microfluidic chips that enable the isolation and analysis of individual cells from complex samples.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州微超生物科技.